Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

Sponsor

Weill Medical College of Cornell University (Other)

Overall Status

Recruiting

CT.gov ID

NCT03149380

Collaborator

(none)

10,000

Enrollment

Location

Arms

Duration (Months)

107.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To evaluate the effectiveness of an online educational course on Alzheimer's disease (AD) prevention, treatment and caregiving.

Condition or Disease	Intervention/Treatment	Phase
Alzheimer Disease Alzheimer Disease, Late Onset Memory Loss Patient Education as Topic	Behavioral: Web-based education	N/A

Detailed Description

Alzheimer's Universe (www.AlzU.org) was created to provide online education about Alzheimer's disease (AD), with a focus on family members of people with AD, people with mild cognitive impairment due to AD and mild AD, caregivers, healthcare providers, medical students, college students and high school students. The website provides evidence-based courses with interactive lessons and activities that have been shown to increase knowledge about AD, willingness to participate in an AD prevention clinical trial, and intent to make specific lifestyle changes in effort to reduce AD risk.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

10000 participants

Allocation:

Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Prevention

Official Title:

Evaluating the Effectiveness of Web-based Education Via Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior: A Randomized Trial

Study Start Date :

Jan 1, 2017

Anticipated Primary Completion Date :

Dec 1, 2023

Anticipated Study Completion Date :

Oct 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Intervention Subjects will be given access to educational content on AD using interactive learning strategies	Behavioral: Web-based education The investigators will utilize interactive lessons and activities to educate about Alzheimer's disease prevention, treatment and caregiving, with focus on evidence-based lifestyle and nutritional recommendations that have been associated with delaying cognitive decline.
Sham Comparator: Time-neutral control Subjects will be given access to time-neutral general educational content on AD	Behavioral: Web-based education The investigators will utilize interactive lessons and activities to educate about Alzheimer's disease prevention, treatment and caregiving, with focus on evidence-based lifestyle and nutritional recommendations that have been associated with delaying cognitive decline.

Arm

Intervention/Treatment

Experimental: Intervention

Subjects will be given access to educational content on AD using interactive learning strategies

Behavioral: Web-based education

The investigators will utilize interactive lessons and activities to educate about Alzheimer's disease prevention, treatment and caregiving, with focus on evidence-based lifestyle and nutritional recommendations that have been associated with delaying cognitive decline.

Sham Comparator: Time-neutral control

Subjects will be given access to time-neutral general educational content on AD

Behavioral: Web-based education

Outcome Measures

Primary Outcome Measures

Knowledge of AD Preventative behaviors [12 months]
Knowledge is calculated as a positive change on multiple-choice questions about AD between pre vs. post-completion of educational material
Willingness to Engage in AD Preventative behaviors [12 months]
Willingness is calculated as a positive change on questionnaires evaluating AD-preventative behaviors between pre vs. post-completion of educational material

Secondary Outcome Measures

Participant Satisfaction [12 months]
The investigators will assess general satisfaction with the educational modules via pre vs post-intervention participant surveys
Behavioral Assessments [12 months]
The investigators will evaluate related behavioral assessments via pre vs post-intervention participant surveys

Eligibility Criteria

Criteria

Ages Eligible for Study:

14 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

greater than or equal to 14 years old with a friend, family member or acquaintance with Alzheimer's disease or memory loss, OR a person diagnosed with mild memory loss (including mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease), OR an AD caregiver, OR healthcare providers, OR a medical student, college student or high school student.

Exclusion Criteria:

< 14 years old, OR diagnosis of moderate or severe Alzheimer's disease

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Weill Medical College of Cornell University	New York	New York	United States	10021

Sponsors and Collaborators

Weill Medical College of Cornell University

Investigators

Principal Investigator: Richard Isaacson, MD, Weill Medical College of Cornell University

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Direct hyperlink to Alzheimer's Universe website

Publications

None provided.

Responsible Party:

Weill Medical College of Cornell University

ClinicalTrials.gov Identifier:

NCT03149380

Other Study ID Numbers:

1311014539

First Posted:

May 11, 2017

Last Update Posted:

Feb 1, 2022

Last Verified:

Jan 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Alzheimer Disease

Memory Disorders

Late Onset Disorders

Study Results

No Results Posted as of Feb 1, 2022